We found that ROR1Neg CLL cells that used either U or M IGHV had levels of ERK1/2 or DOCK2 that were comparable to that of ROR1Pos CLL cells (Fig. 5a). Here, MAPK3 is linked to B-cell chronic lymphocytic leukemia.